Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed [NA]

View source ↗

Summary

Clinical trial evaluating the optimal dose of proton pump inhibitors after an upper gastrointestinal bleed was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Upper Gastrointestinal Bleed | NA | Status: TERMINATED | Results posted: 2017-07-02